Lili Kotmayer

HCEMM-SU Molecular Oncohematology Research Group

Home > Teams > Genomic Instability and Cancer > HCEMM – SU Molecular Oncohematology Research Group > Members > Lili Kotmayer

Lili Kotmayer

PUBLICATIONS CONTACT

EDUCATION

2020- Doctoral School of Pathology, Semmelweis University
2016- Faculty of Medicine, Semmelweis UniversityGPA (9 semesters): 4,73
2012-2016 ELTE Apáczai Csere János High School, BudapestGPA: 5,0
2008-2012 Prohászka Ottokár Catholic High School,

LANGUAGE EXAMS

2013 English, Level B2 complex language exam
2016 Latin, Level B2 complex language exam

SCIENTIFIC ACTIVITY

2018-Member of Korányi Frigyes College for Advanced Studies
Member of the Scientific Committee(2019-)
II. Semmelweis Talent Conference, member of the organizing committee(2020)

2019- Kerpel-Fronius Ödön Talent Program membership Mentor: Dr. Gergely Kriván
2019-Hungarian Medical Association of America (HMAA) junior membership

ACHIEVEMENTS

2016-1stDepartment of Pathology and Experimental Cancer Research, Semmelweis UniversityMTA-SEMomentum Molecular Oncohematology Research GroupSupervisors: Dr. Csaba Bödör,Dr. Richárd Kiss, Dr.DonátAlpár
2019-1st Department of Pathology and Experimental Cancer Research, Semmelweis University, student secretaryfor Scientific Student Research(TDK)
2019-Semmelweis University, Scientific Student Committee (TDT) membership
2019Screening for genomic copy number alterations in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification
Semmelweis University TDK Conference –1stPrizeNational TDKConference, Debrecen, participant
2020 Screening for DNA copy number alterations in the oncohaematologic diagnostics using multiplex ligation-dependent probe amplification Semmelweis University Rectorial Competition –1stPrize
2020 Next-generation sequencing methods in oncohematological diagnostics and therapySemmelweis University ScientificCompetition –1stPrize
2020 Kerpel-Fronius Talent PrizeKerpel-Fronius Ödön Talent Program
2020 Mutational profilingof 50 Hungarianpediatric AML patients with next-generationsequencingSemmelweis University TDK Conference –2ndPrize
2021 Screening and monitoring of BTKC481S mutation in patients with relapsed/refractory chronic lymphocytic leukemia during ibrutinib therapySemmelweis University TDK Conference –2nd Prize
2021Screening and monitoring of BTKC481S mutation in patients with relapsed/refractory chronic lymphocytic leukemia during ibrutinib therapyNational TDKConference–1stPrize
2021 Screening and monitoring of BTKC481S mutation in patients with relapsed/refractory chronic lymphocytic leukemia during ibrutinib therapyXVII. Burdenko International Scientific Conference–1stPrize

Publications

6. Screening and monitoring of BTKC481S mutation in patients with relapsed/refractory chronic lymphocytic leukemia during ibrutinib therapy

Csaba Bödör, Lili Kotmayer, ESH 1stTranslational Research Conference on Chronic Lymphocytic Leukemia, 17 Nov 2020, Online conference, oral poster presentation

5. Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma

Ákos Nagy, Bence Bátai, Alexandra Balogh, Sarolta Illés, Gábor Mikala, Noémi Nagy, Laura Kiss, Lili Kotmayer, András Matolcsy, Donát Alpár, Tamás Masszi, András Masszi, Csaba Bödör, 2020, Genes, 11(7):785

4. Hereditary haematological malignancies

Lili Kotmayer, Krisztián Kállay, Csaba Bödör, 2020, Magyar Onkológia, 64(1), pp. 43-55

3. Screening for genomic copy number alterations in a family suffering from myelodysplastic syndrome using multiplex ligation-dependent probe amplification

Lili Kotmayer, Richárd Kiss, Attila Péter Király, Judit Csomor, Krisztián Kállay, Donát Alpár, Csaba Bödör, 2018, Hematológia–Transzfuziológia, 51(4), 214-220

2. Screening for genomic copy number alterations in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification

Richárd Kiss, Gergő Papp, Szilvia Krizsán, Lili Kotmayer, Ambrus Gángó, Noémi Nagy, Bence Bátai, Zoltán Mátrai, Csaba Bödör, Donár Alpár, 2018, Hematológia–Transzfuziológia, 51(1), pp. 31-40

1. Screening for genomic copy number alterations in a family suffering from myelodysplastic syndrome using multiplex ligation-dependent probe amplification

LiliKotmayer, 27thCongress of the Hungarian Society of Haematology and Transfusion, 23 May 2019, Pécs, poster

HCEMM-SU Molecular Oncohematology Research Group

Lili Kotmayer

Lili Kotmayer

EDUCATION

LANGUAGE EXAMS

SCIENTIFIC ACTIVITY

ACHIEVEMENTS

Publications

6. Screening and monitoring of BTKC481S mutation in patients with relapsed/refractory chronic lymphocytic leukemia during ibrutinib therapy

5. Quantitative Analysis and Monitoring of EZH2 Mutations Using Liquid Biopsy in Follicular Lymphoma

4. Hereditary haematological malignancies

3. Screening for genomic copy number alterations in a family suffering from myelodysplastic syndrome using multiplex ligation-dependent probe amplification

2. Screening for genomic copy number alterations in chronic lymphocytic leukemia using multiplex ligation-dependent probe amplification

1. Screening for genomic copy number alterations in a family suffering from myelodysplastic syndrome using multiplex ligation-dependent probe amplification

Awards

Consortium

About HCEMM

Internal Policies

Contact Info